Review



hy 108937 d 64131 mce  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    MedChemExpress hy 108937 d 64131 mce
    Hy 108937 D 64131 Mce, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 12 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nsc+15364/NSC+15364/pm40614706-670-85-87
    Average 93 stars, based on 12 article reviews
    hy 108937 d 64131 mce - by Bioz Stars, 2026-10
    93/100 stars

    Images

    Related Articles

    Virus:

    Article Title: Amyloid beta glycation leads to 1 neuronal mitochondrial dysfunction and Alzheimer’s pathogenesis through VDAC1-dependent mtDNA efflux
    Article Snippet: The App knock-in mouse model (App SAA KI/KI; B6.Cg-Apptm1.1Dnli/J, Jackson Lab # 034711) of Alzheimer’s disease (AD) was used which carries humanizing Aβ region R684H, F681Y, and G676R mutations, and the KM670/671NL (Swedish) mutation in exon 16 as well as the E693G (Arctic) and T714I (Austrian) mutations in exon 17 of the mouse App (amyloid beta (A4) precursor protein) gene.

    Recombinant:

    Article Title: Amyloid beta glycation leads to 1 neuronal mitochondrial dysfunction and Alzheimer’s pathogenesis through VDAC1-dependent mtDNA efflux
    Article Snippet: The App knock-in mouse model (App SAA KI/KI; B6.Cg-Apptm1.1Dnli/J, Jackson Lab # 034711) of Alzheimer’s disease (AD) was used which carries humanizing Aβ region R684H, F681Y, and G676R mutations, and the KM670/671NL (Swedish) mutation in exon 16 as well as the E693G (Arctic) and T714I (Austrian) mutations in exon 17 of the mouse App (amyloid beta (A4) precursor protein) gene.

    Injection:

    Article Title: Amyloid beta glycation leads to 1 neuronal mitochondrial dysfunction and Alzheimer’s pathogenesis through VDAC1-dependent mtDNA efflux
    Article Snippet: The App knock-in mouse model (App SAA KI/KI; B6.Cg-Apptm1.1Dnli/J, Jackson Lab # 034711) of Alzheimer’s disease (AD) was used which carries humanizing Aβ region R684H, F681Y, and G676R mutations, and the KM670/671NL (Swedish) mutation in exon 16 as well as the E693G (Arctic) and T714I (Austrian) mutations in exon 17 of the mouse App (amyloid beta (A4) precursor protein) gene.

    Saline:

    Article Title: Amyloid beta glycation leads to 1 neuronal mitochondrial dysfunction and Alzheimer’s pathogenesis through VDAC1-dependent mtDNA efflux
    Article Snippet: The App knock-in mouse model (App SAA KI/KI; B6.Cg-Apptm1.1Dnli/J, Jackson Lab # 034711) of Alzheimer’s disease (AD) was used which carries humanizing Aβ region R684H, F681Y, and G676R mutations, and the KM670/671NL (Swedish) mutation in exon 16 as well as the E693G (Arctic) and T714I (Austrian) mutations in exon 17 of the mouse App (amyloid beta (A4) precursor protein) gene.

    Mouse Assay:

    Article Title: Amyloid beta glycation leads to 1 neuronal mitochondrial dysfunction and Alzheimer’s pathogenesis through VDAC1-dependent mtDNA efflux
    Article Snippet: The App knock-in mouse model (App SAA KI/KI; B6.Cg-Apptm1.1Dnli/J, Jackson Lab # 034711) of Alzheimer’s disease (AD) was used which carries humanizing Aβ region R684H, F681Y, and G676R mutations, and the KM670/671NL (Swedish) mutation in exon 16 as well as the E693G (Arctic) and T714I (Austrian) mutations in exon 17 of the mouse App (amyloid beta (A4) precursor protein) gene.



    Similar Products

    93
    MedChemExpress hy 108937 d 64131 mce
    Hy 108937 D 64131 Mce, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nsc+15364/NSC+15364/pm40614706-670-85-87
    Average 93 stars, based on 1 article reviews
    hy 108937 d 64131 mce - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    98
    MedChemExpress hy 15141 nsc 15364 mce
    Hy 15141 Nsc 15364 Mce, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nsc+15364/Staurosporine/pm40614706-670-81-83
    Average 98 stars, based on 1 article reviews
    hy 15141 nsc 15364 mce - by Bioz Stars, 2026-10
    98/100 stars
      Buy from Supplier

    93
    MedChemExpress nsc 15364
    Nsc 15364, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nsc+15364/NSC+15364/pm40517916-60-33-38
    Average 93 stars, based on 1 article reviews
    nsc 15364 - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    93
    MedChemExpress apoptosis inhibitor
    Apoptosis Inhibitor, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nsc+15364/NSC+15364/pmc11617880-382-0-27
    Average 93 stars, based on 1 article reviews
    apoptosis inhibitor - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    93
    MedChemExpress nsc15364
    A H1299 cells were transfected with GFP or GFP-VDAC1 for 18 h and subsequently treated with a control or cysteine-deprived medium for the indicated time. B H1299 cells were co-transfected with CTL or VDAC1 siRNAs along with GFP or GFP-VDAC1 for 24 h. C H1299 cells were transfected with GFP or GFP-VDAC1 for 18 h and subsequently treated with 100 μM <t>NSC15364</t> or 400 μM DIDS for 12 h. A – C The indicated protein levels were estimated by western blot analysis. Band intensities of GFP-VDAC1 were quantified using Image ( J ), normalized to β-actin intensity, and plotted as a fold change relative to the control. D H1299 cells were transfected with GFP or GFP-VDAC1 for 18 h and subsequently treated with a control or cysteine-deprived medium for the indicated time. E H1299 cells were transfected with Flag or Flag-VDAC1 for 24 h. The indicated mRNA levels were estimated by quantitative real-time PCR analysis ( n = 3; *** p < 0.001). F H1299 cells were transfected with Flag or Flag-VDAC1 for 18 h and subsequently treated with control or cysteine-deprived medium for 9 h. G , H H1299 cells were co-transfected with CTL or VDAC1 siRNAs along with Flag or Flag-VDAC1 for 18 h and subsequently treated with control or cysteine-deprived medium for the indicated time ( H ) or 9 h ( G ). I , J H1299 cells were incubated in a control or cysteine-deprived medium with or without NSC15364 or DIDS for the indicated concentration for 24 h. D , H , I , and J Cell viability was measured by MTT assay ( n = 3; *** p < 0.001). K – N H1299 cells were incubated in a control or cysteine-deprived medium with or without 100 μM NSC15364 or 400 μM DIDS for 12 h. F , G A representative flow cytometry of the average MFI ± SD of C11-BODIPY staining ( n = 3; *** p < 0.001, ns not significantly different). K , L A representative flow cytometry histogram of C11-BODIPY staining (upper panels) and the average MFI ± SD of C11-BODIPY staining (low panels) ( n = 3; *** p < 0.001, ns not significantly different). M , N A representative flow cytometry histogram of MitoPeDPP staining (upper panels) and the average MFI ± SD of MitoPeDPP staining (low panels) ( n = 3; *** p < 0.001, ns not significantly different). CTL control, Cys cysteine, MFI mean fluorescence intensity, NSC NSC15364, SD standard deviation.
    Nsc15364, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nsc+15364/NSC+15364/pmc11550314-38-5-10
    Average 93 stars, based on 1 article reviews
    nsc15364 - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    93
    MedChemExpress gemcitabine
    A H1299 cells were transfected with GFP or GFP-VDAC1 for 18 h and subsequently treated with a control or cysteine-deprived medium for the indicated time. B H1299 cells were co-transfected with CTL or VDAC1 siRNAs along with GFP or GFP-VDAC1 for 24 h. C H1299 cells were transfected with GFP or GFP-VDAC1 for 18 h and subsequently treated with 100 μM <t>NSC15364</t> or 400 μM DIDS for 12 h. A – C The indicated protein levels were estimated by western blot analysis. Band intensities of GFP-VDAC1 were quantified using Image ( J ), normalized to β-actin intensity, and plotted as a fold change relative to the control. D H1299 cells were transfected with GFP or GFP-VDAC1 for 18 h and subsequently treated with a control or cysteine-deprived medium for the indicated time. E H1299 cells were transfected with Flag or Flag-VDAC1 for 24 h. The indicated mRNA levels were estimated by quantitative real-time PCR analysis ( n = 3; *** p < 0.001). F H1299 cells were transfected with Flag or Flag-VDAC1 for 18 h and subsequently treated with control or cysteine-deprived medium for 9 h. G , H H1299 cells were co-transfected with CTL or VDAC1 siRNAs along with Flag or Flag-VDAC1 for 18 h and subsequently treated with control or cysteine-deprived medium for the indicated time ( H ) or 9 h ( G ). I , J H1299 cells were incubated in a control or cysteine-deprived medium with or without NSC15364 or DIDS for the indicated concentration for 24 h. D , H , I , and J Cell viability was measured by MTT assay ( n = 3; *** p < 0.001). K – N H1299 cells were incubated in a control or cysteine-deprived medium with or without 100 μM NSC15364 or 400 μM DIDS for 12 h. F , G A representative flow cytometry of the average MFI ± SD of C11-BODIPY staining ( n = 3; *** p < 0.001, ns not significantly different). K , L A representative flow cytometry histogram of C11-BODIPY staining (upper panels) and the average MFI ± SD of C11-BODIPY staining (low panels) ( n = 3; *** p < 0.001, ns not significantly different). M , N A representative flow cytometry histogram of MitoPeDPP staining (upper panels) and the average MFI ± SD of MitoPeDPP staining (low panels) ( n = 3; *** p < 0.001, ns not significantly different). CTL control, Cys cysteine, MFI mean fluorescence intensity, NSC NSC15364, SD standard deviation.
    Gemcitabine, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nsc+15364/NSC+15364/pm38602878-315-11-31
    Average 93 stars, based on 1 article reviews
    gemcitabine - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    Image Search Results


    A H1299 cells were transfected with GFP or GFP-VDAC1 for 18 h and subsequently treated with a control or cysteine-deprived medium for the indicated time. B H1299 cells were co-transfected with CTL or VDAC1 siRNAs along with GFP or GFP-VDAC1 for 24 h. C H1299 cells were transfected with GFP or GFP-VDAC1 for 18 h and subsequently treated with 100 μM NSC15364 or 400 μM DIDS for 12 h. A – C The indicated protein levels were estimated by western blot analysis. Band intensities of GFP-VDAC1 were quantified using Image ( J ), normalized to β-actin intensity, and plotted as a fold change relative to the control. D H1299 cells were transfected with GFP or GFP-VDAC1 for 18 h and subsequently treated with a control or cysteine-deprived medium for the indicated time. E H1299 cells were transfected with Flag or Flag-VDAC1 for 24 h. The indicated mRNA levels were estimated by quantitative real-time PCR analysis ( n = 3; *** p < 0.001). F H1299 cells were transfected with Flag or Flag-VDAC1 for 18 h and subsequently treated with control or cysteine-deprived medium for 9 h. G , H H1299 cells were co-transfected with CTL or VDAC1 siRNAs along with Flag or Flag-VDAC1 for 18 h and subsequently treated with control or cysteine-deprived medium for the indicated time ( H ) or 9 h ( G ). I , J H1299 cells were incubated in a control or cysteine-deprived medium with or without NSC15364 or DIDS for the indicated concentration for 24 h. D , H , I , and J Cell viability was measured by MTT assay ( n = 3; *** p < 0.001). K – N H1299 cells were incubated in a control or cysteine-deprived medium with or without 100 μM NSC15364 or 400 μM DIDS for 12 h. F , G A representative flow cytometry of the average MFI ± SD of C11-BODIPY staining ( n = 3; *** p < 0.001, ns not significantly different). K , L A representative flow cytometry histogram of C11-BODIPY staining (upper panels) and the average MFI ± SD of C11-BODIPY staining (low panels) ( n = 3; *** p < 0.001, ns not significantly different). M , N A representative flow cytometry histogram of MitoPeDPP staining (upper panels) and the average MFI ± SD of MitoPeDPP staining (low panels) ( n = 3; *** p < 0.001, ns not significantly different). CTL control, Cys cysteine, MFI mean fluorescence intensity, NSC NSC15364, SD standard deviation.

    Journal: Cell Death & Disease

    Article Title: Inhibition of VDAC1 oligomerization blocks cysteine deprivation-induced ferroptosis via mitochondrial ROS suppression

    doi: 10.1038/s41419-024-07216-1

    Figure Lengend Snippet: A H1299 cells were transfected with GFP or GFP-VDAC1 for 18 h and subsequently treated with a control or cysteine-deprived medium for the indicated time. B H1299 cells were co-transfected with CTL or VDAC1 siRNAs along with GFP or GFP-VDAC1 for 24 h. C H1299 cells were transfected with GFP or GFP-VDAC1 for 18 h and subsequently treated with 100 μM NSC15364 or 400 μM DIDS for 12 h. A – C The indicated protein levels were estimated by western blot analysis. Band intensities of GFP-VDAC1 were quantified using Image ( J ), normalized to β-actin intensity, and plotted as a fold change relative to the control. D H1299 cells were transfected with GFP or GFP-VDAC1 for 18 h and subsequently treated with a control or cysteine-deprived medium for the indicated time. E H1299 cells were transfected with Flag or Flag-VDAC1 for 24 h. The indicated mRNA levels were estimated by quantitative real-time PCR analysis ( n = 3; *** p < 0.001). F H1299 cells were transfected with Flag or Flag-VDAC1 for 18 h and subsequently treated with control or cysteine-deprived medium for 9 h. G , H H1299 cells were co-transfected with CTL or VDAC1 siRNAs along with Flag or Flag-VDAC1 for 18 h and subsequently treated with control or cysteine-deprived medium for the indicated time ( H ) or 9 h ( G ). I , J H1299 cells were incubated in a control or cysteine-deprived medium with or without NSC15364 or DIDS for the indicated concentration for 24 h. D , H , I , and J Cell viability was measured by MTT assay ( n = 3; *** p < 0.001). K – N H1299 cells were incubated in a control or cysteine-deprived medium with or without 100 μM NSC15364 or 400 μM DIDS for 12 h. F , G A representative flow cytometry of the average MFI ± SD of C11-BODIPY staining ( n = 3; *** p < 0.001, ns not significantly different). K , L A representative flow cytometry histogram of C11-BODIPY staining (upper panels) and the average MFI ± SD of C11-BODIPY staining (low panels) ( n = 3; *** p < 0.001, ns not significantly different). M , N A representative flow cytometry histogram of MitoPeDPP staining (upper panels) and the average MFI ± SD of MitoPeDPP staining (low panels) ( n = 3; *** p < 0.001, ns not significantly different). CTL control, Cys cysteine, MFI mean fluorescence intensity, NSC NSC15364, SD standard deviation.

    Article Snippet: DIDS sodium salt (#HY-D0086) and NSC15364 (#HY-108937) were obtained from MedChemExpress (Monmouth Junction, NJ, USA).

    Techniques: Transfection, Control, Western Blot, Real-time Polymerase Chain Reaction, Incubation, Concentration Assay, MTT Assay, Flow Cytometry, Staining, Fluorescence, Standard Deviation

    A – E H1299 cells were incubated in a control or cysteine-deprived medium with or without 100 μM NSC15364 or 400 μM DIDS for 12 h. A A representative fluorescence microscopy image of MitoSOX red staining. The green fluorescence of MitoBright LT green shows the location of mitochondria (scale bar = 100 μm). B , C A representative flow cytometry histogram of MitoSOX staining (upper panels) and the average MFI ± SD of MitoSOX staining (low panels) ( n = 3; * p < 0.05, *** p < 0.001, ns not significantly different). D , E A representative flow cytometry histogram of TMRE staining. F H1299 cells were incubated in a control or cysteine-deprived medium with or without 100 μM NSC15364 or 400 μM DIDS for 2 h. The oxygen consumption was measured using an extracellular oxygen consumption assay. The dots represent the values of oxygen consumption measured at 1.5-min intervals over a period of 180 min. H1299 cells treated with 75 μM Antimycin A for 2 h were used as a positive control for oxygen consumption rate inhibition, ( n = 3; *** p < 0.001, ns not significantly different). Anti A antimycin A, Cys cysteine, MFI mean fluorescence intensity, NSC NSC15364, SD standard deviation, TMRE tetramethylrhodamine ethyl ester perchlorate.

    Journal: Cell Death & Disease

    Article Title: Inhibition of VDAC1 oligomerization blocks cysteine deprivation-induced ferroptosis via mitochondrial ROS suppression

    doi: 10.1038/s41419-024-07216-1

    Figure Lengend Snippet: A – E H1299 cells were incubated in a control or cysteine-deprived medium with or without 100 μM NSC15364 or 400 μM DIDS for 12 h. A A representative fluorescence microscopy image of MitoSOX red staining. The green fluorescence of MitoBright LT green shows the location of mitochondria (scale bar = 100 μm). B , C A representative flow cytometry histogram of MitoSOX staining (upper panels) and the average MFI ± SD of MitoSOX staining (low panels) ( n = 3; * p < 0.05, *** p < 0.001, ns not significantly different). D , E A representative flow cytometry histogram of TMRE staining. F H1299 cells were incubated in a control or cysteine-deprived medium with or without 100 μM NSC15364 or 400 μM DIDS for 2 h. The oxygen consumption was measured using an extracellular oxygen consumption assay. The dots represent the values of oxygen consumption measured at 1.5-min intervals over a period of 180 min. H1299 cells treated with 75 μM Antimycin A for 2 h were used as a positive control for oxygen consumption rate inhibition, ( n = 3; *** p < 0.001, ns not significantly different). Anti A antimycin A, Cys cysteine, MFI mean fluorescence intensity, NSC NSC15364, SD standard deviation, TMRE tetramethylrhodamine ethyl ester perchlorate.

    Article Snippet: DIDS sodium salt (#HY-D0086) and NSC15364 (#HY-108937) were obtained from MedChemExpress (Monmouth Junction, NJ, USA).

    Techniques: Incubation, Control, Fluorescence, Microscopy, Staining, Flow Cytometry, Positive Control, Inhibition, Standard Deviation

    A H1299 cells were treated with 200 nM RSL3 and 100 μM NSC15364 for 18 h. Cell viability was measured by MTT assay, ( n = 3; * p < 0.05, *** p < 0.001). B – E H1299 cells were treated with 200 nM RSL3 and 100 μM NSC15364 for 9 h. B A representative flow cytometry histogram of C11-BODIPY staining (left panel) and the average MFI ± SD of C11-BODIPY staining (right panel) ( n = 3; *** p < 0.001, ns not significantly different). C A representative flow cytometry histogram of MitoPeDPP staining (left panel) and the average MFI ± SD of MitoPeDPP staining (right panel) ( n = 3; ** p < 0.01, *** p < 0.001). D A representative flow cytometry histogram of MitoSOX staining (left panel) and the average MFI ± SD of MitoSOX staining (right panel) ( n = 3; *** p < 0.001, ns not significantly different). E A representative flow cytometry histogram of TMRE staining (left panel) and the average MFI ± SD of TMRE staining (right panel) ( n = 3; *** p < 0.001, ns not significantly different). F H1299 cells were treated with 200 nM RSL3 and 100 μM NSC15364 for 2 h. The oxygen consumption was measured using an extracellular oxygen consumption assay. The dots represent the values of oxygen consumption measured at 1.5-min intervals over a period of 180 min. H1299 cells treated with 75 μM Antimycin A for 2 h were used as a positive control for oxygen consumption rate inhibition, ( n = 3; *** p < 0.001). Anti A antimycin A, Cys cysteine, MFI mean fluorescence intensity, NSC NSC15364, SD standard deviation, TMRE tetramethylrhodamine ethyl ester perchlorate.

    Journal: Cell Death & Disease

    Article Title: Inhibition of VDAC1 oligomerization blocks cysteine deprivation-induced ferroptosis via mitochondrial ROS suppression

    doi: 10.1038/s41419-024-07216-1

    Figure Lengend Snippet: A H1299 cells were treated with 200 nM RSL3 and 100 μM NSC15364 for 18 h. Cell viability was measured by MTT assay, ( n = 3; * p < 0.05, *** p < 0.001). B – E H1299 cells were treated with 200 nM RSL3 and 100 μM NSC15364 for 9 h. B A representative flow cytometry histogram of C11-BODIPY staining (left panel) and the average MFI ± SD of C11-BODIPY staining (right panel) ( n = 3; *** p < 0.001, ns not significantly different). C A representative flow cytometry histogram of MitoPeDPP staining (left panel) and the average MFI ± SD of MitoPeDPP staining (right panel) ( n = 3; ** p < 0.01, *** p < 0.001). D A representative flow cytometry histogram of MitoSOX staining (left panel) and the average MFI ± SD of MitoSOX staining (right panel) ( n = 3; *** p < 0.001, ns not significantly different). E A representative flow cytometry histogram of TMRE staining (left panel) and the average MFI ± SD of TMRE staining (right panel) ( n = 3; *** p < 0.001, ns not significantly different). F H1299 cells were treated with 200 nM RSL3 and 100 μM NSC15364 for 2 h. The oxygen consumption was measured using an extracellular oxygen consumption assay. The dots represent the values of oxygen consumption measured at 1.5-min intervals over a period of 180 min. H1299 cells treated with 75 μM Antimycin A for 2 h were used as a positive control for oxygen consumption rate inhibition, ( n = 3; *** p < 0.001). Anti A antimycin A, Cys cysteine, MFI mean fluorescence intensity, NSC NSC15364, SD standard deviation, TMRE tetramethylrhodamine ethyl ester perchlorate.

    Article Snippet: DIDS sodium salt (#HY-D0086) and NSC15364 (#HY-108937) were obtained from MedChemExpress (Monmouth Junction, NJ, USA).

    Techniques: MTT Assay, Flow Cytometry, Staining, Positive Control, Inhibition, Fluorescence, Standard Deviation

    A , B MDA-MB-231 cells were incubated in a control or cysteine-deprived medium with or without NSC15364 or DIDS for the indicated concentration for 24 h. C , D HEYA8 cells were incubated in a control or cysteine-deprived medium with or without NSC15364 or DIDS for the indicated concentration for 24 h. A – D Cell viability was measured by MTT assay ( n = 3). E , G , I , and K MDA-MB-231 cells were incubated in a control or cysteine-deprived medium with or without 100 μM NSC15364 or 400 μM DIDS for 12 h. F , H , J , and L HEYA8 cells were incubated in a control or cysteine-deprived medium with or without 100 μM NSC15364 or 400 μM DIDS for 16 h. E , F A representative flow cytometry histogram of C11-BODIPY staining (upper panels) and the average MFI ± SD of C11-BODIPY staining (low panels) ( n = 3; ** p < 0.01, *** p < 0.001, ns not significantly different). G , H A representative flow cytometry histogram of MitoPeDPP staining (upper panels) and the average MFI ± SD of MitoPeDPP staining (low panels) ( n = 3; * p < 0.05, *** p < 0.001). I , J A representative flow cytometry histogram of MitoSOX. K , L A representative flow cytometry histogram of TMRE. Cys cysteine, MFI mean fluorescence intensity, NSC NSC15364, SD standard deviation, TMRE tetramethylrhodamine ethyl ester perchlorate.

    Journal: Cell Death & Disease

    Article Title: Inhibition of VDAC1 oligomerization blocks cysteine deprivation-induced ferroptosis via mitochondrial ROS suppression

    doi: 10.1038/s41419-024-07216-1

    Figure Lengend Snippet: A , B MDA-MB-231 cells were incubated in a control or cysteine-deprived medium with or without NSC15364 or DIDS for the indicated concentration for 24 h. C , D HEYA8 cells were incubated in a control or cysteine-deprived medium with or without NSC15364 or DIDS for the indicated concentration for 24 h. A – D Cell viability was measured by MTT assay ( n = 3). E , G , I , and K MDA-MB-231 cells were incubated in a control or cysteine-deprived medium with or without 100 μM NSC15364 or 400 μM DIDS for 12 h. F , H , J , and L HEYA8 cells were incubated in a control or cysteine-deprived medium with or without 100 μM NSC15364 or 400 μM DIDS for 16 h. E , F A representative flow cytometry histogram of C11-BODIPY staining (upper panels) and the average MFI ± SD of C11-BODIPY staining (low panels) ( n = 3; ** p < 0.01, *** p < 0.001, ns not significantly different). G , H A representative flow cytometry histogram of MitoPeDPP staining (upper panels) and the average MFI ± SD of MitoPeDPP staining (low panels) ( n = 3; * p < 0.05, *** p < 0.001). I , J A representative flow cytometry histogram of MitoSOX. K , L A representative flow cytometry histogram of TMRE. Cys cysteine, MFI mean fluorescence intensity, NSC NSC15364, SD standard deviation, TMRE tetramethylrhodamine ethyl ester perchlorate.

    Article Snippet: DIDS sodium salt (#HY-D0086) and NSC15364 (#HY-108937) were obtained from MedChemExpress (Monmouth Junction, NJ, USA).

    Techniques: Incubation, Control, Concentration Assay, MTT Assay, Flow Cytometry, Staining, Fluorescence, Standard Deviation